Cargando…

Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy

IMPORTANCE: This study quantifies the trends in trimodality therapy use and its association with pathologic stage and overall survival of patients with rectal cancer at the population level. OBJECTIVE: To describe changes between 2006 and 2016 in the sequence and use of chemotherapy/radiation therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kennecke, Hagen F., Bahnson, Henry T., Lin, Bruce, O’Rourke, Colin, Kaplan, Jennifer, Pham, Huong, Suen, Andrew, Simianu, Vlad V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389431/ https://www.ncbi.nlm.nih.gov/pubmed/35980607 http://dx.doi.org/10.1001/jamaoncol.2022.2831

Ejemplares similares

Contemporary, national patterns of surgery after preoperative therapy for stage II/III rectal adenocarcinoma
por: Soriano, Celine, et al.
Publicado: (2022)

Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
por: So, Michelle, et al.
Publicado: (2020)

Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer
por: Su, Alan, et al.
Publicado: (2023)

Clinical outcomes of pancoast tumors treated with trimodality therapy
por: Lin, Tami Yu-Yu, et al.
Publicado: (2021)

Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
por: Dan, Aravot, et al.
Publicado: (2019)

A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes
por: Ylescupidez, Alyssa, et al.
Publicado: (2023)

Presentation and management of a case of rectal cancer complicated by perforation and necrotizing soft tissue infection
por: Cragle, Chad E, et al.
Publicado: (2022)

Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
por: Aravot, Dan, et al.
Publicado: (2019)

Personalized trimodal prehabilitation for gastrectomy
por: Bausys, Augustinas, et al.
Publicado: (2020)

Anaplastic thyroid cancer: outcomes of trimodal therapy
por: Houlihan, Orla A., et al.
Publicado: (2021)

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results
por: Kennecke, Hagen F., et al.
Publicado: (2023)

The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation
por: Dudani, Shaan, et al.
Publicado: (2021)

Defining the window of opportunity and target populations to prevent peanut allergy
por: Roberts, Graham, et al.
Publicado: (2023)

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients
por: FUJIWARA, YOSHINORI, et al.
Publicado: (2012)

A case report of the rarest anal cancer: Basal cell carcinoma
por: Tung, Jivatesh, et al.
Publicado: (2022)

Trimodal therapy in squamous cell carcinoma of the esophagus
por: Matuschek, C, et al.
Publicado: (2011)

Bipolar disorder: Trimodal age‐at‐onset distribution
por: Bolton, Sorcha, et al.
Publicado: (2020)

Trimodal Therapy: A Tumor Vascular‐Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia (Adv. Sci. 8/2018)
por: Luan, Xin, et al.
Publicado: (2018)

Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014)

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer
por: Guo, Yadong, et al.
Publicado: (2019)

Severe Thrombocytopenia in Patients With Advanced Neuroendocrine Tumor Treated With Peptide Receptor Radioligand Therapy
por: Naveed Ahmad, Junid A., et al.
Publicado: (2022)

Using Capture-Recapture Methods to Estimate the Population of People Who Inject Drugs in Washington, DC
por: Ruiz, Monica S., et al.
Publicado: (2015)

How far will they go?: assessing the travel distance of current and former drug users to access harm reduction services
por: Allen, Sean, et al.
Publicado: (2015)

Trimodality therapy in variant urothelial carcinoma: choose wisely
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2017)

Trimodality therapy of malignant pleural mesothelioma with helical tomotherapy
por: Ozyurt, Hazan, et al.
Publicado: (2023)

An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer
por: Lee, Jung-Yun, et al.
Publicado: (2016)

Conditional survival of trimodal therapy for nonmetastatic muscle‐invasive bladder cancer: A SEER database analysis
por: Shangguan, Wentai, et al.
Publicado: (2022)

Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapy
por: Tang, Andrew, et al.
Publicado: (2022)

Early results of a trimodality treatment for superior sulcus tumors
por: Łapiński, Mariusz, et al.
Publicado: (2014)

Developing Hollow-Channel Gold Nanoflowers as Trimodal Intracellular Nanoprobes
por: Ye, Sunjie, et al.
Publicado: (2018)

Trimodal Race Model Inequalities in Multisensory Integration: I. Basics
por: Colonius, Hans, et al.
Publicado: (2017)

Fullerol Nanocatalysis and Trimodal Surface Plasmon Resonance for the Determination of Isocarbophos
por: Ouyang, Huixiang, et al.
Publicado: (2020)

Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review
por: Decazes, Pierre, et al.
Publicado: (2021)

Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience
por: Polineni, Praneet, et al.
Publicado: (2021)

Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients
por: Wadhwa, Roopma, et al.
Publicado: (2017)

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy
por: Kool, Ronald, et al.
Publicado: (2021)

Diverticulitis is a population health problem: Lessons and gaps in strategies to implement and improve contemporary care
por: Stovall, Stephanie Lee, et al.
Publicado: (2023)

The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy
por: Yang, Hui, et al.
Publicado: (2021)

Trimodality Therapy for Bladder Preservation in the Elderly Population with Invasive Bladder Cancer
por: Turgeon, Guy-Anne, et al.
Publicado: (2014)

Multisensory effects on somatosensation: a trimodal visuo-vestibular-tactile interaction
por: Kaliuzhna, Mariia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s3dn72e5kg0i3731nvapb9p4md